Acute Lymphoblastic Leukemia (ALL): A Comprehensive Overview

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer diagnosed worldwide, with a smaller incidence peak in later middle age. This aggressive form of cancer requires a deep understanding of its molecular biology, and modern genetic profiling techniques are paving the way for significant advances in diagnosis, prognostication, and therapy selection.

The ongoing refinement of risk-adapted frontline treatment protocols, coupled with the use of novel targeted therapies and better supportive care, is leading to improved outcomes for patients with ALL.

Understanding Acute Lymphoblastic Leukemia

Fast Facts: Acute Lymphoblastic Leukemia is a comprehensive guide that delves into the epidemiology, etiology, diagnosis, and classification of ALL. The book also explores the measurement of minimal residual disease to determine prognosis, providing invaluable insights for healthcare professionals and researchers alike.

What You’ll Learn

• Epidemiology, pathophysiology, and etiology of ALL
• Diagnosis and classification of ALL
• Prognostic factors and measurement of minimal residual disease
• Frontline therapies and treatment of relapsed and refractory ALL
• The role of newer targeted agents and allogeneic stem-cell transplantation
• Future directions and refinements in ALL research and treatment

This book serves as an essential resource for healthcare professionals, researchers, and patients seeking to understand the complexities of ALL and stay abreast of the latest advancements in diagnosis, treatment, and research.

Book Details

Product Details:

• ISBN: B0B47QPV91
• Publisher: S. Karger
• Publication Date: June 30, 2022
• Language: English
• Screen Reader: Supported
• Sticky notes: On Kindle Scribe